Thu. 9 May 2024, 4:46pm ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
Dianthus Therapeutics (NASDAQ:DNTH) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.44) by 22.73 percent. The company reported quarterly sales of $874.00 thousand which beat the analyst consensus estimate of $460.00 thousand by 90.00 percent.